SLILATY STEVE N. 1474684 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-12 | 2024-02-08 | 2024-02-08 | 4 | Slilaty Steve N. | CEO | acq | 20000.0 | 66.67 | 7.79 | 0.1 | Direct | Series B Preferred Stock | SUNSHINE BIOPHARMA, INC | code P | 30000.0 | 25.68 (SBFM) |
| 2024-03-05 | 2024-03-04 | 2024-03-04 | 4 | Slilaty Steve N. | CEO | acq | 100000.0 | 76.92 | 38.94 | 0.1 | Direct | Series B Preferred Stock | SUNSHINE BIOPHARMA, INC | code P | 130000.0 | 25.68 (SBFM) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)